Singapore, June 16 -- Novatrials, Australia's largest independently owned clinical trials site, is excited to announce its newly constructed Phase 1 facility, is now accepting study proposals. Renowned for delivering exceptional Phase 1, 2 and 3 services to leading global pharmaceutical and biotech companies for over a decade, Novatrials has expanded to meet rising demand with this state-of-the-art facility.

Spanning over 2,000 square meters, this brand-new, purpose-built site is fully equipped with cutting-edge technology. Once fully operational, it will feature a 31-bed inpatient unit, dedicated outpatient consultation rooms, a full suite of business offices, a comprehensive clinical laboratory, an on-site compounding pharmacy, and oth...